GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Epsilon Healthcare Ltd (FRA:9TH0) » Definitions » EV-to-EBIT

Epsilon Healthcare (FRA:9TH0) EV-to-EBIT : -1.67 (As of Jun. 10, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Epsilon Healthcare EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Epsilon Healthcare's Enterprise Value is €5.84 Mil. Epsilon Healthcare's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €-3.49 Mil. Therefore, Epsilon Healthcare's EV-to-EBIT for today is -1.67.

The historical rank and industry rank for Epsilon Healthcare's EV-to-EBIT or its related term are showing as below:

FRA:9TH0' s EV-to-EBIT Range Over the Past 10 Years
Min: -28.48   Med: -2.49   Max: -0.59
Current: -1.76

During the past 6 years, the highest EV-to-EBIT of Epsilon Healthcare was -0.59. The lowest was -28.48. And the median was -2.49.

FRA:9TH0's EV-to-EBIT is not ranked
in the Drug Manufacturers industry.
Industry Median: 16.54 vs FRA:9TH0: -1.76

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Epsilon Healthcare's Enterprise Value for the quarter that ended in Jun. 2023 was €3.49 Mil. Epsilon Healthcare's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €-3.49 Mil. Epsilon Healthcare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -99.91%.


Epsilon Healthcare EV-to-EBIT Historical Data

The historical data trend for Epsilon Healthcare's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epsilon Healthcare EV-to-EBIT Chart

Epsilon Healthcare Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBIT
Get a 7-Day Free Trial -6.32 -4.33 -4.22 -1.91 -0.77

Epsilon Healthcare Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -1.91 - -0.77 -

Competitive Comparison of Epsilon Healthcare's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Epsilon Healthcare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Epsilon Healthcare's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Epsilon Healthcare's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Epsilon Healthcare's EV-to-EBIT falls into.



Epsilon Healthcare EV-to-EBIT Calculation

Epsilon Healthcare's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=5.838/-3.486
=-1.67

Epsilon Healthcare's current Enterprise Value is €5.84 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Epsilon Healthcare's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €-3.49 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Epsilon Healthcare  (FRA:9TH0) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Epsilon Healthcare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2023 ) =EBIT / Enterprise Value (Q: Jun. 2023 )
=-3.486/3.489301
=-99.91 %

Epsilon Healthcare's Enterprise Value for the quarter that ended in Jun. 2023 was €3.49 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Epsilon Healthcare's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €-3.49 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Epsilon Healthcare EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Epsilon Healthcare's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Epsilon Healthcare (FRA:9TH0) Business Description

Traded in Other Exchanges
Address
35 Lime Street, Suite 305, Level 3, Sydney, NSW, AUS, 2000
Epsilon Healthcare Ltd is a diversified global healthcare and pharmaceuticals company. It owns number of medicinal cannabis assets including the cannabis manufacturing facility in the Southern Hemisphere, the Tetra Health clinic, and the Medimar Platform an end to end ecommerce solution for nutraceuticals and cannabis. EPN additionally operates a turn-key cannabis cultivation solutions provider based in Vancouver, Canada.

Epsilon Healthcare (FRA:9TH0) Headlines

No Headlines